Veru Inc.

VERU ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Revenue $16.9M $16.3M $39.4M $61.3M $42.6M $31.8M $15.9M $13.7M
Cost of Revenue $11.0M $8.7M $8.8M $13.3M $11.8M $10.1M $7.1M $6.6M
Gross Profit $5.9M $7.6M $30.6M $47.9M $30.8M $21.7M $8.8M $7.0M
Gross Margin 34.7% 46.4% 77.7% 78.2% 72.3% 68.1% 55.3% 51.4%
Operating Expenses
Research & Development $12.8M $51.2M $70.9M $32.7M $16.9M $13.7M $10.9M $3.1M
SG&A Expense $31.2M $48.1M $43.2M $20.7M $14.5M $14.3M $14.8M $11.5M
Operating Income $-36.2M $-93.8M $-83.5M $13.0M $-14.7M $-6.4M $-20.9M $-8.5M
Operating Margin -214.2% -575.5% -212.1% 21.2% -34.6% -20.2% -131.6% -62.2%
Interest Expense — $2.4M $4.4M $4.9M $4.6M $4.7M $3.0M —
Pretax Income — $-92.7M $-83.8M $4.3M $-20.1M $-12.3M $-23.1M $-8.6M
Income Tax Expense $0 $480.2K $236.4K $-3.1M $-1.1M $-303.9K $866.1K $-2.0M
Net Income $-37.8M $-93.2M $-84.0M $7.4M $-19.0M $-12.0M $-23.9M $-6.6M
Net Margin -223.9% -571.6% -213.5% 12.1% -44.5% -37.8% -150.9% -48.4%
EPS (Basic) $-2.80 $-1.10 $-1.05 $0.10 $-0.28 $-0.19 $-0.44 $-0.25
EPS (Diluted) — $-1.10 $-1.05 $0.09 $-0.28 $-0.19 $-0.44 $-0.25
Shares Outstanding (Basic) 13.5M 85.0M 80.1M 76.3M 66.8M 65.0M 62.6M 34.6M
Shares Outstanding (Diluted) 13.5M 85.0M 80.1M 83.8M 66.8M 65.0M 62.6M 34.6M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →